BIO Statement on Removal of Patent Legislation from Judiciary Committee Agenda
This statement originally appeared in BIO.org on May 21, 2014.
Washington, D.C. (May 21, 2014) – The Biotechnology Industry Organization today issued the following statement in response to Senator Patrick Leahy’s announcement that he will remove current patent legislation from the Senate Judiciary Committee’s agenda for now:
“BIO applauds Chairman Leahy’s decision to remove the controversial patent bill from the Senate Judiciary Committee’s agenda until greater stakeholder consensus can be achieved.
“Effective patent litigation reform legislation can and must address the scourge of patent trolls while protecting America’s innovators, including small businesses, inventors, universities and life sciences companies. We stand ready to support Chairman Leahy in reaching a more targeted agreement that focuses on the problem of patent trolls.”
# # #
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter.